Larsson K - Search Results

1

Aspects on pathophysiological mechanisms in COPD.

Larsson K. Larsson K. J Intern Med. 2007 Sep;262(3):311-40. doi: 10.1111/j.1365-2796.2007.01837.x. J Intern Med. 2007. PMID: 17697154 Free article. Review.

2

Inflammatory markers in COPD.

Larsson K. Larsson K. Clin Respir J. 2008 Oct;2 Suppl 1:84-7. doi: 10.1111/j.1752-699X.2008.00089.x. Clin Respir J. 2008. PMID: 20298355 Review.

3

Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, Larsson LG, Andersson S, Sandström T, Larsson K; Obstructive Lung Disease in Northern Sweden Studies. Lundbäck B, et al. Among authors: larsson lg, larsson k. Respir Med. 2003 Feb;97(2):115-22. doi: 10.1053/rmed.2003.1446. Respir Med. 2003. PMID: 12587960 Free article.

4

Toll-like receptor expression in smokers with and without COPD.

von Scheele I, Larsson K, Dahlén B, Billing B, Skedinger M, Lantz AS, Palmberg L. von Scheele I, et al. Among authors: larsson k. Respir Med. 2011 Aug;105(8):1222-30. doi: 10.1016/j.rmed.2011.02.012. Epub 2011 Mar 24. Respir Med. 2011. PMID: 21439805 Free article.

5

Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.

Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G. Larsson K, et al. J Intern Med. 2013 Jun;273(6):584-94. doi: 10.1111/joim.12067. Epub 2013 Apr 1. J Intern Med. 2013. PMID: 23495860 Free article.

6

Low awareness of COPD among physicians.

Sundblad BM, Larsson K, Nathell L. Sundblad BM, et al. Among authors: larsson k. Clin Respir J. 2008 Jan;2(1):11-6. doi: 10.1111/j.1752-699X.2007.00020.x. Clin Respir J. 2008. PMID: 20298299

7

Dental health in smokers with and without COPD.

Bergström J, Cederlund K, Dahlén B, Lantz AS, Skedinger M, Palmberg L, Sundblad BM, Larsson K. Bergström J, et al. Among authors: larsson k. PLoS One. 2013;8(3):e59492. doi: 10.1371/journal.pone.0059492. Epub 2013 Mar 27. PLoS One. 2013. PMID: 23544074 Free PMC article.

8

Cholinergic mechanisms in an organic dust model simulating an acute exacerbation in patients with COPD.

Palmberg L, Sundblad BM, Ji J, Karén J, Larsson K. Palmberg L, et al. Among authors: larsson k. Int J Chron Obstruct Pulmon Dis. 2018 Nov 1;13:3611-3624. doi: 10.2147/COPD.S171495. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30464444 Free PMC article.

9

[Management of COPD].

Larsson K. Larsson K. Lakartidningen. 2007 Mar 28-Apr 3;104(13):1043-6. Lakartidningen. 2007. PMID: 17476907 Review. Swedish. No abstract available.

10

Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness.

Strandberg K, Ek A, Palmberg L, Larsson K. Strandberg K, et al. Among authors: larsson k. J Intern Med. 2008 Jul;264(1):83-94. doi: 10.1111/j.1365-2796.2008.01928.x. Epub 2008 Feb 21. J Intern Med. 2008. PMID: 18298484 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,057 results

Search Page